206 related articles for article (PubMed ID: 26525720)
41. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
42. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
Punglia RS; Schnitt SJ; Weeks JC
J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
[TBL] [Abstract][Full Text] [Related]
43. Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS).
De Morgan SE; Butow PN; Lobb EA; Price MA; Nehill C
Support Care Cancer; 2011 May; 19(5):717-23. PubMed ID: 21088858
[TBL] [Abstract][Full Text] [Related]
44. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.
Wang SY; Kuntz K; Tuttle T; Kane R
Breast Cancer Res Treat; 2010 Nov; 124(2):393-402. PubMed ID: 20848183
[TBL] [Abstract][Full Text] [Related]
45. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
46. Renaming ductal carcinoma in situ: would removing "carcinoma" reduce overtreatment?
Javid SH; Fang LC; Korde L; Anderson BO
J Natl Compr Canc Netw; 2014 Apr; 12(4):599-602. PubMed ID: 24717574
[No Abstract] [Full Text] [Related]
47. Estimating the magnitude of clinical benefit of local therapy in patients with DCIS.
Hwang ES; Malek V
Breast; 2019 Nov; 48 Suppl 1():S34-S38. PubMed ID: 31839157
[TBL] [Abstract][Full Text] [Related]
48. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; McCormick B; Moran MS; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Sitapati A; Smith KL; Smith ML; Soliman H; Somlo G; Telli ML; Ward JH; Kumar R; Shead DA
J Natl Compr Canc Netw; 2018 Mar; 16(3):310-320. PubMed ID: 29523670
[TBL] [Abstract][Full Text] [Related]
49. DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).
Galimberti V; Monti S; Mastropasqua MG
Breast; 2013 Aug; 22(4):431-5. PubMed ID: 23643807
[TBL] [Abstract][Full Text] [Related]
50. [Ductal carcinoma in situ: current anatomo-pathologic data].
Fiche M
Rev Med Suisse Romande; 2003 May; 123(5):295-8. PubMed ID: 15095712
[TBL] [Abstract][Full Text] [Related]
51. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Sagara Y; Mallory MA; Wong S; Aydogan F; DeSantis S; Barry WT; Golshan M
JAMA Surg; 2015 Aug; 150(8):739-45. PubMed ID: 26039049
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.
Schnitt SJ
Mod Pathol; 2021 Jan; 34(Suppl 1):1-7. PubMed ID: 32908254
[TBL] [Abstract][Full Text] [Related]
53. A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ.
Lo AC; Olson R; Feldman-Stewart D; Truong PT; Aquino-Parsons C; Bottorff JL; Carolan H
Am J Clin Oncol; 2017 Dec; 40(6):574-581. PubMed ID: 25730602
[TBL] [Abstract][Full Text] [Related]
54. Ductal carcinoma in situ: should the name be changed?
Graff S
J Natl Cancer Inst; 2010 Jan; 102(1):6-8. PubMed ID: 20023202
[No Abstract] [Full Text] [Related]
55. A Call for Change in the Diagnosis and Treatment of Patients with Ductal Carcinoma In Situ: An Opportunity to Minimize Overdiagnosis and Overtreatment.
Masood S
Breast J; 2015; 21(6):575-8. PubMed ID: 26547899
[No Abstract] [Full Text] [Related]
56. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
Masood S
Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
[TBL] [Abstract][Full Text] [Related]
57. Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.
Bober SL; Giobbie-Hurder A; Emmons KM; Winer E; Partridge A
J Sex Med; 2013 Feb; 10(2):370-7. PubMed ID: 22812628
[TBL] [Abstract][Full Text] [Related]
58. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
59. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
60. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
